Heart Failure Pharmacology
Sort by:
Top Ten Topics in Clinical Cardiology 2021
Optimizing Heart Failure Therapy: Selection, Sequence, Substitution?
FEATURING
Javed Butler
- 1,278 views
- November 2, 2021
- 16
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Management of Sleep Disordered Breathing in Heart Failure: What Are the Benefits of Treating Obstructive Sleep Apnea with Positive Airway Pressure? How to Treat Central Sleep Apnea?
FEATURING
Robert Owens
- 1,280 views
- February 8, 2021
- 15
26th Annual San Diego Heart Failure Symposium
Broadening Indications for the Use of Angiotensin Receptor Neprilysin Inhibitors in Patients with HFrEF, ADHF and HFpEF
FEATURING
Clyde Yancy
- 1,027 views
- December 16, 2020
- 15
Mount Sinai Advanced Heart Symposium 2016
Chronic Heart Failure Update: Incorporating Sacubatril / Valsartan and Ivabradine into Clinical Practice
FEATURING
Sean Pinney
- 1,622 views
- February 14, 2017
- 14
UCLA Health
2023 State of the Art Medication Therapies for Heart Failure
FEATURING
Gregg Fonarow
- 1,356 views
- October 12, 2023
- 14
Scripps Health
Hypertrophic Cardiomyopathy: MRI to Mavacamten
FEATURING
Jorge Gonzalez
- 1,214 views
- November 15, 2021
- 14
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,406 views
- January 27, 2022
- 15
Houston Methodist DeBakey Heart and Vascular Center
Group 2 Pulmonary Hypertension: Isn't it Just Heart Failure?
FEATURING
Hyeon-Ju Ali
- 1,333 views
- June 14, 2023
- 14
Jefferson Health
2022 Heart Failure Guidelines Review
FEATURING
Donald Haas
- 748 views
- April 24, 2023
- 14
Texas Cardiovascular Innovations Conference 2021
New Heart Failure Treatment Recommendations
FEATURING
Albert Hicks
- 2,272 views
- March 3, 2022
- 14
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Advances in Temporary Mechanical Support for Acute Heart Failure: What Pharmacological Agents Do We Have and What Are Their Detrimental Effects? When to Use IABP, Impella, Tandem Heart and ECMO?
FEATURING
Ryan Reeves
- 1,701 views
- February 8, 2021
- 12
American Heart & Vascular Institute
Heart Failure With Preserved Ejection Fraction: Is the New Paradigm Treatment Finally Here? Insights from the EMPEROR-Preserved Trial
FEATURING
Javed Butler
- 1,739 views
- September 9, 2021
- 12
ACC 2024 Insights
ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optimal Outcomes
FEATURING
Kim Williams
- 1,573 views
- April 26, 2024
- 13
Canadian Collaborative Research Network
HFpEF: Which Drugs Have Become Standard Care?
FEATURING
Milan Gupta
- 1,695 views
- June 13, 2022
- 12
NYU Langone
Emerging Therapies in Cardiac Amyloidosis
FEATURING
Mazen Hanna
- 790 views
- June 8, 2022
- 13
MUSC Cardiology
Inotropic Treatment for HFpEF? An Idea So Crazy It Just Might Be Right
FEATURING
Sheldon Litwin
- 1,077 views
- November 8, 2022
- 13
Cardiology Fiesta 2018
Heart Failure and Atrial Fibrillation – What Is the Right Approach for Your Patient?
FEATURING
Jayasree Pillarisetti
- 1,857 views
- November 28, 2018
- 12
Courage and Innovation Symposium: Heart Failure & Heart Transplantation
Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sight
FEATURING
Nitasha Sarswat
- 1,261 views
- April 27, 2022
- 13
Scripps Health
Heart Failure: Guideline Based and Novel Therapies
FEATURING
Rola Khedraki
- 1,101 views
- June 13, 2023
- 11
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments
FEATURING
Rajeev C. Mohan
- 727 views
- June 13, 2023
- 10